Prioritizing candidate peptides for cancer vaccines through predicting peptide presentation by HLA‐I proteins
Author
Abstract
Suggested Citation
DOI: 10.1111/biom.13717
Download full text from publisher
References listed on IDEAS
- Derin B. Keskin & Annabelle J. Anandappa & Jing Sun & Itay Tirosh & Nathan D. Mathewson & Shuqiang Li & Giacomo Oliveira & Anita Giobbie-Hurder & Kristen Felt & Evisa Gjini & Sachet A. Shukla & Zhutin, 2019. "Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial," Nature, Nature, vol. 565(7738), pages 234-239, January.
- Elise Alspach & Danielle M. Lussier & Alexander P. Miceli & Ilya Kizhvatov & Michel DuPage & Adrienne M. Luoma & Wei Meng & Cheryl F. Lichti & Ekaterina Esaulova & Anthony N. Vomund & Daniele Runci & , 2019. "MHC-II neoantigens shape tumour immunity and response to immunotherapy," Nature, Nature, vol. 574(7780), pages 696-701, October.
- Moshe Sade-Feldman & Yunxin J. Jiao & Jonathan H. Chen & Michael S. Rooney & Michal Barzily-Rokni & Jean-Pierre Eliane & Stacey L. Bjorgaard & Marc R. Hammond & Hans Vitzthum & Shauna M. Blackmon & De, 2017. "Resistance to checkpoint blockade therapy through inactivation of antigen presentation," Nature Communications, Nature, vol. 8(1), pages 1-11, December.
- Sebastian Kreiter & Mathias Vormehr & Niels van de Roemer & Mustafa Diken & Martin Löwer & Jan Diekmann & Sebastian Boegel & Barbara Schrörs & Fulvia Vascotto & John C. Castle & Arbel D. Tadmor & Step, 2015. "Mutant MHC class II epitopes drive therapeutic immune responses to cancer," Nature, Nature, vol. 520(7549), pages 692-696, April.
- Amanda Finck & Saar I. Gill & Carl H. June, 2020. "Cancer immunotherapy comes of age and looks for maturity," Nature Communications, Nature, vol. 11(1), pages 1-4, December.
- Sebastian Kreiter & Mathias Vormehr & Niels van de Roemer & Mustafa Diken & Martin Löwer & Jan Diekmann & Sebastian Boegel & Barbara Schrörs & Fulvia Vascotto & John C. Castle & Arbel D. Tadmor & Step, 2015. "Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer," Nature, Nature, vol. 523(7560), pages 370-370, July.
- Patrick A. Ott & Zhuting Hu & Derin B. Keskin & Sachet A. Shukla & Jing Sun & David J. Bozym & Wandi Zhang & Adrienne Luoma & Anita Giobbie-Hurder & Lauren Peter & Christina Chen & Oriol Olive & Todd , 2017. "An immunogenic personal neoantigen vaccine for patients with melanoma," Nature, Nature, vol. 547(7662), pages 217-221, July.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Qing Li & Hao Zeng & Ting Liu & Peipei Wang & Rui Zhang & Binyan Zhao & Tang Feng & Yuling Yang & Jiumei Wu & Yue Zheng & Bailing Zhou & Yang Shu & Heng Xu & Li Yang & Zhenyu Ding, 2024. "A dendritic cell vaccine for both vaccination and neoantigen-reactive T cell preparation for cancer immunotherapy in mice," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
- Ariel Isser & Aliyah B. Silver & Hawley C. Pruitt & Michal Mass & Emma H. Elias & Gohta Aihara & Si-Sim Kang & Niklas Bachmann & Ying-Yu Chen & Elissa K. Leonard & Joan G. Bieler & Worarat Chaisawangw, 2022. "Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
- Laurel B. Darragh & Jacob Gadwa & Tiffany T. Pham & Benjamin Court & Brooke Neupert & Nicholas A. Olimpo & Khoa Nguyen & Diemmy Nguyen & Michael W. Knitz & Maureen Hoen & Sophia Corbo & Molishree Josh, 2022. "Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
- Christian J. Maine & Shigeki J. Miyake-Stoner & Darina S. Spasova & Gaelle Picarda & Annie C. Chou & Emily D. Brand & Melanie D. Olesiuk & Christine C. Domingo & Hunter J. Little & Thomas T. Goodman &, 2025. "Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers," Nature Communications, Nature, vol. 16(1), pages 1-13, December.
- Szymon J. Szymura & Lin Wang & Tiantian Zhang & Soung-chul Cha & Joo Song & Zhenyuan Dong & Aaron Anderson & Elizabeth Oh & Vincent Lee & Zhe Wang & Sapna Parshottam & Sheetal Rao & Jasper B. Olsem & , 2024. "Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
- Xinyuan Lei & Hsinyu Lin & Jieqi Wang & Zhanpeng Ou & Yi Ruan & Ananthan Sadagopan & Weixiong Chen & Shule Xie & Baisheng Chen & Qunxing Li & Jue Wang & Huayue Lin & Xiaofeng Zhu & Xiaoqing Yuan & Tia, 2022. "Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
- Georges Bedran & Daniel A. Polasky & Yi Hsiao & Fengchao Yu & Felipe Veiga Leprevost & Javier A. Alfaro & Marcin Cieslik & Alexey I. Nesvizhskii, 2023. "Unraveling the glycosylated immunopeptidome with HLA-Glyco," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
- Meghana Pagadala & Timothy J. Sears & Victoria H. Wu & Eva Pérez-Guijarro & Hyo Kim & Andrea Castro & James V. Talwar & Cristian Gonzalez-Colin & Steven Cao & Benjamin J. Schmiedel & Shervin Goudarzi , 2023. "Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
- Jens Bauer & Natalie Köhler & Yacine Maringer & Philip Bucher & Tatjana Bilich & Melissa Zwick & Severin Dicks & Annika Nelde & Marissa Dubbelaar & Jonas Scheid & Marcel Wacker & Jonas S. Heitmann & S, 2022. "The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
- Hakimeh Ebrahimi-Nik & Marmar Moussa & Ryan P. Englander & Summit Singhaviranon & Justine Michaux & HuiSong Pak & Hiroko Miyadera & William L. Corwin & Grant L. J. Keller & Adam T. Hagymasi & Tatiana , 2021. "Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
- Dinh-Huy Nguyen & Sung-Hwan You & Hien Thi-Thu Ngo & Khuynh Nguyen & Khang Vuong Tran & Tan-Huy Chu & So-young Kim & Sang-Jun Ha & Yeongjin Hong & Jung-Joon Min, 2024. "Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
- Kevin B. Weyant & Ayomide Oloyede & Sukumar Pal & Julie Liao & Mariela Rivera-De Jesus & Thapakorn Jaroentomeechai & Tyler D. Moeller & Steven Hoang-Phou & Sean F. Gilmore & Riya Singh & Daniel C. Pan, 2023. "A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
- Denise Lau & Sonal Khare & Michelle M. Stein & Prerna Jain & Yinjie Gao & Aicha BenTaieb & Tim A. Rand & Ameen A. Salahudeen & Aly A. Khan, 2022. "Integration of tumor extrinsic and intrinsic features associates with immunotherapy response in non-small cell lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
- John P. Finnigan & Jenna H. Newman & Yury Patskovsky & Larysa Patskovska & Andrew S. Ishizuka & Geoffrey M. Lynn & Robert A. Seder & Michelle Krogsgaard & Nina Bhardwaj, 2024. "Structural basis for self-discrimination by neoantigen-specific TCRs," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
- Rasha Barakat & Jit Chatterjee & Rui Mu & Xuanhe Qi & Xingxing Gu & Igor Smirnov & Olivia Cobb & Karen Gao & Angelica Barnes & Jonathan Kipnis & David H. Gutmann, 2024. "Human single cell RNA-sequencing reveals a targetable CD8+ exhausted T cell population that maintains mouse low-grade glioma growth," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
- Franziska Füchsl & Johannes Untch & Vladyslav Kavaka & Gabriela Zuleger & Sarah Braun & Antonia Schwanzer & Sebastian Jarosch & Carolin Vogelsang & Niklas Andrade Krätzig & Dario Gosmann & Rupert Ölli, 2024. "High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
- Ariane F. Busso-Lopes & Leandro X. Neves & Guilherme A. Câmara & Daniela C. Granato & Marco Antônio M. Pretti & Henry Heberle & Fábio M. S. Patroni & Jamile Sá & Sami Yokoo & César Rivera & Romênia R., 2022. "Connecting multiple microenvironment proteomes uncovers the biology in head and neck cancer," Nature Communications, Nature, vol. 13(1), pages 1-24, December.
- Teresa Maria Rosaria Noviello & Anna Maria Giacomo & Francesca Pia Caruso & Alessia Covre & Roberta Mortarini & Giovanni Scala & Maria Claudia Costa & Sandra Coral & Wolf H. Fridman & Catherine Sautès, 2023. "Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
- Xiulan Lai & Wenrui Hao & Avner Friedman, 2020. "TNF-α inhibitor reduces drug-resistance to anti-PD-1: A mathematical model," PLOS ONE, Public Library of Science, vol. 15(4), pages 1-21, April.
- Miles C. Andrews & Junna Oba & Chang-Jiun Wu & Haifeng Zhu & Tatiana Karpinets & Caitlin A. Creasy & Marie-Andrée Forget & Xiaoxing Yu & Xingzhi Song & Xizeng Mao & A. Gordon Robertson & Gabriele Roma, 2022. "Multi-modal molecular programs regulate melanoma cell state," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:biomet:v:79:y:2023:i:3:p:2664-2676. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.blackwellpublishing.com/journal.asp?ref=0006-341X .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.